279 related articles for article (PubMed ID: 34650674)
1. The role of Wnt/β-catenin signaling pathway in the pathogenesis and treatment of multiple myeloma (review).
Yuan Y; Guo M; Gu C; Yang Y
Am J Transl Res; 2021; 13(9):9932-9949. PubMed ID: 34650674
[TBL] [Abstract][Full Text] [Related]
2. Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma.
Qiang YW; Barlogie B; Rudikoff S; Shaughnessy JD
Bone; 2008 Apr; 42(4):669-80. PubMed ID: 18294945
[TBL] [Abstract][Full Text] [Related]
3. Increased NF-κB Activity and Decreased Wnt/β-Catenin Signaling Mediate Reduced Osteoblast Differentiation and Function in ΔF508 Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Mice.
Le Henaff C; Mansouri R; Modrowski D; Zarka M; Geoffroy V; Marty C; Tarantino N; Laplantine E; Marie PJ
J Biol Chem; 2015 Jul; 290(29):18009-18017. PubMed ID: 26060255
[TBL] [Abstract][Full Text] [Related]
4. Wnt signaling in multiple myeloma: a central player in disease with therapeutic potential.
Spaan I; Raymakers RA; van de Stolpe A; Peperzak V
J Hematol Oncol; 2018 May; 11(1):67. PubMed ID: 29776381
[TBL] [Abstract][Full Text] [Related]
5. Production of Wnt inhibitors by myeloma cells: potential effects on canonical Wnt pathway in the bone microenvironment.
Giuliani N; Morandi F; Tagliaferri S; Lazzaretti M; Donofrio G; Bonomini S; Sala R; Mangoni M; Rizzoli V
Cancer Res; 2007 Aug; 67(16):7665-74. PubMed ID: 17702698
[TBL] [Abstract][Full Text] [Related]
6. ERβ induces the differentiation of cultured osteoblasts by both Wnt/β-catenin signaling pathway and estrogen signaling pathways.
Yin X; Wang X; Hu X; Chen Y; Zeng K; Zhang H
Exp Cell Res; 2015 Jul; 335(1):107-14. PubMed ID: 25957463
[TBL] [Abstract][Full Text] [Related]
7. Aberrantly expressed LGR4 empowers Wnt signaling in multiple myeloma by hijacking osteoblast-derived R-spondins.
van Andel H; Ren Z; Koopmans I; Joosten SP; Kocemba KA; de Lau W; Kersten MJ; de Bruin AM; Guikema JE; Clevers H; Spaargaren M; Pals ST
Proc Natl Acad Sci U S A; 2017 Jan; 114(2):376-381. PubMed ID: 28028233
[TBL] [Abstract][Full Text] [Related]
8. LncRNA TUG1 influences osteoblast proliferation and differentiation through the Wnt/β-catenin signaling pathway.
Liu SC; Sun QZ; Qiao XF; Li XG; Yang JH; Wang TQ; Xiao YJ; Qiao JM
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4584-4590. PubMed ID: 31210284
[TBL] [Abstract][Full Text] [Related]
9. Small molecules from natural products targeting the Wnt/β-catenin pathway as a therapeutic strategy.
Liu D; Chen L; Zhao H; Vaziri ND; Ma SC; Zhao YY
Biomed Pharmacother; 2019 Sep; 117():108990. PubMed ID: 31226638
[TBL] [Abstract][Full Text] [Related]
10. Low-level laser irradiation promotes the differentiation of bone marrow stromal cells into osteoblasts through the APN/Wnt/β-catenin pathway.
Zhang RF; Wang Q; Zhang AA; Xu JG; Zhai LD; Yang XM; Liu XT
Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2860-2868. PubMed ID: 29771444
[TBL] [Abstract][Full Text] [Related]
11. Fluoride promotes osteoblastic differentiation through canonical Wnt/β-catenin signaling pathway.
Pan L; Shi X; Liu S; Guo X; Zhao M; Cai R; Sun G
Toxicol Lett; 2014 Feb; 225(1):34-42. PubMed ID: 24300170
[TBL] [Abstract][Full Text] [Related]
12. Syndecan-1 promotes Wnt/β-catenin signaling in multiple myeloma by presenting Wnts and R-spondins.
Ren Z; van Andel H; de Lau W; Hartholt RB; Maurice MM; Clevers H; Kersten MJ; Spaargaren M; Pals ST
Blood; 2018 Mar; 131(9):982-994. PubMed ID: 29212806
[TBL] [Abstract][Full Text] [Related]
13. Aberrant Wnt signaling in multiple myeloma: molecular mechanisms and targeting options.
van Andel H; Kocemba KA; Spaargaren M; Pals ST
Leukemia; 2019 May; 33(5):1063-1075. PubMed ID: 30770859
[TBL] [Abstract][Full Text] [Related]
14. Chrysosplenetin promotes osteoblastogenesis of bone marrow stromal cells via Wnt/β-catenin pathway and enhances osteogenesis in estrogen deficiency-induced bone loss.
Hong G; He X; Shen Y; Chen X; Yang F; Yang P; Pang F; Han X; He W; Wei Q
Stem Cell Res Ther; 2019 Aug; 10(1):277. PubMed ID: 31464653
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Wnt/β-catenin signaling promotes epithelial differentiation of mesenchymal stem cells and repairs bleomycin-induced lung injury.
Wang C; Zhu H; Sun Z; Xiang Z; Ge Y; Ni C; Luo Z; Qian W; Han X
Am J Physiol Cell Physiol; 2014 Aug; 307(3):C234-44. PubMed ID: 24898581
[TBL] [Abstract][Full Text] [Related]
16. Synergistic Efficacy of the Demethylation Agent Decitabine in Combination With the Protease Inhibitor Bortezomib for Treating Multiple Myeloma Through the Wnt/β-Catenin Pathway.
Jin Y; Xu L; Wu X; Feng J; Shu M; Gu H; Gao G; Zhang J; Dong B; Chen X
Oncol Res; 2019 Jun; 27(6):729-737. PubMed ID: 30837032
[TBL] [Abstract][Full Text] [Related]
17. Runx2 Controls Bone Resorption through the Down-Regulation of the Wnt Pathway in Osteoblasts.
Haxaire C; Haÿ E; Geoffroy V
Am J Pathol; 2016 Jun; 186(6):1598-609. PubMed ID: 27083516
[TBL] [Abstract][Full Text] [Related]
18. Berberine promotes bone marrow-derived mesenchymal stem cells osteogenic differentiation via canonical Wnt/β-catenin signaling pathway.
Tao K; Xiao D; Weng J; Xiong A; Kang B; Zeng H
Toxicol Lett; 2016 Jan; 240(1):68-80. PubMed ID: 26478571
[TBL] [Abstract][Full Text] [Related]
19. A novel Sprouty4-ERK1/2-Wnt/β-catenin regulatory loop in marrow stromal progenitor cells controls osteogenic and adipogenic differentiation.
Tian L; Xiao H; Li M; Wu X; Xie Y; Zhou J; Zhang X; Wang B
Metabolism; 2020 Apr; 105():154189. PubMed ID: 32105664
[TBL] [Abstract][Full Text] [Related]
20. Attenuated Wnt/β-catenin signalling mediates methotrexate chemotherapy-induced bone loss and marrow adiposity in rats.
Georgiou KR; King TJ; Scherer MA; Zhou H; Foster BK; Xian CJ
Bone; 2012 Jun; 50(6):1223-33. PubMed ID: 22484100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
